Stakeholders’ Consulting Group

Stakeholders’ Consulting Group

ICE-HBV collaborates with key stakeholders to accelerate research in HBV cure. ICE-HBV Stakeholders’ Consulting Group gathers them annually to provide input on the development of ICE-HBV global research roadmap, share information about HBV cure programmes and identify potential synergies and collaborations areas.

The Stakeholders’ Consulting Group provides advice to researchers working towards the discovery of a safe, affordable, scalable and effective Hepatitis B cure. 

The group is working on the following 3-pillars of HBV Cure preparedness, to ensure the timely and effective transition of research discoveries:

  • Health Policy (gaps analysis and HBV cure funding mapping)

  • Community Engagement:

    • Scientific Literacy

    • Clinical Trials Engagement

  • Clinical Care Delivery & Cost-Effectiveness

The Group is co-chaired by Timothy Block (Hepatitis B Foundation), Veronica Miller (HBV Forum) and Ulrike Protzer (DZIF).

Current Members:

Alex Ng, Bill and Melinda Gates Foundation (Beijing)

Benjamin Cowie,  WHO Collaborating Centre for Viral Hepatitis at Doherty Institute

Brian McMahon, World Indigenous Peoples' Conference on Viral Hepatitis

Cecil K. Dovia, Cedaku Foundation/Ghana Health Centre

Christian Bréchot, Global Virus Network

Chris Muñoz, Yellow Warriors Society Philippines

Dee Lee, Inno Community Development China

Emma Day,  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)

Fernando Contreras, ALEH

François Dabis, ANRS

Helen Tyrell, Hepatitis Australia

Jeffrey V. Lazarus, Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona

Jennifer Johnston, CEVHAP

Joan Block, Hepatitis B Foundation

Marc Bulterys, Global Hepatitis Programme, HIV/Hepatitis Department, World Health Organization

Maud Lemoine, MRC Gambia/Prolifica

Mehlika Toy, Asian Liver Centre at Stanford University

Michael Ninburg, Hepatitis Education Project

Rajen Koshi, National Institute of Allergy and Infectious Diseases

Raquel Peck, World Hepatitis Alliance

Samuel So, Asian Liver Centre at Stanford University

Stephen Locarnini, CEVHAP

Su Wang, World Hepatitis Alliance

Timothy Block, Hepatitis B Foundation

Ulrike Protzer, DZIF

Veronica Miller, HBV Forum

Ventzislava Petrov-Sanchez, ANRS

William Phelps,  American Cancer Society, Inc.

Stakeholders Consulting Group ToRs - V1 April 2017